Rising incidences of
cancer worldwide, technological advancements in oncological diagnostic
techniques, and increasing demand for effective screening tests are some of the
major factors propelling demand in the cancer diagnostics market, according to
a study by IndustryARC. The report estimated the global cancer diagnostics
market to have been valued at $135 billion in 2018, and projects it to
increase at a CAGR of 6.2% during the forecast period 2019 to 2025.
The report titled,
‘Cancer Diagnostics Market: By Product Type (Next-generation Sequencing,
Microarrays, PCR, Flow Cytometry, In situ Hybridization, Others), Cancer Type
(Breast, Ovarian, Thyroid, Kidney, Blood, Prostate, Others) & By Geography
– Forecast (2019 - 2025)’, describes imperative aspects of the industry including
market drivers, market value chain, restraints, growth indicators, market
trends, challenges, future outlook, and market insights.
Cancer Diagnostics Market: Leading
Segments
In the global cancer diagnostics market, North America
registered the highest share of demand at 37% in 2018. Growing usage of latest
technologies for treatment, rising awareness pertaining to cancer treatment,
and increase in the reported incidences of cancer coupled with easy access
to highly developed healthcare infrastructure contribute to North America’s
dominance in the global cancer diagnostics market. According to the National
Cancer Institute, breast cancer is not only the most diagnosed type of cancer
among women, it is also the most common cancer diagnosed for both
genders. Key market players are thus capitalizing on this application segment,
which is expected to grow at a CAGR of 28% through to 2025.
Cancer Diagnostics Market Disruptive
Trends
Some of the latest disruptive trends are listed below:
· Cancer
Diagnostics Augmented by Artificial Intelligence and Machine Learning:
Ongoing research pertaining to use of machine learning
and natural language processing to create targeted cancer treatments, pair
machine learning with computer vision, help identify tumour progression, and creating
algorithms that help scientists understand how cancer develops and how to fight
them is expected to boost demand for the cancer diagnostics market.
· Nanotechnology
for Cancer Diagnostics:
Nanoscale devices are 100 to 10000 times smaller than
human cells, which enable them to gain access to inconspicuous areas of the
body in order to detect diseases and facilitate new ways of treatment.
· CAR-T
cell therapy:
Chimeric Antigen Receptor Therapy (CAR-T) cell
therapy, a type of immunotherapy, is one of the most promising advancements in
the healthcare industry. It isolates and extracts a patient’s own T-cells, and
reengineers those cells with new proteins that recognize and destroy cancer
cells once they’re reinfused back into the patient’s body.
· Advanced
Blood Test:
Liquid biopsies assess mutations and other changes in
DNA from tumor cells in the blood, and thus provide insight during early stages
of cancer. This non-invasive cancer test continues to show promise as a
tool for routine cancer screenings and as a potential alternative to tumor
biopsy.
Cancer Diagnostics Market: Competitive
Landscape
Some of the key companies identified in the report that are currently holding majority share in the global cancer diagnostics market are: BioMark Diagnostics Inc., Biotheranostics, Inc., Cancer Diagnostics, Inc., Arquer Diagnostics Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, GE Healthcare, QIAGEN N.V., Thermo Fisher Scientific, Inc., and Illumina, Inc.
Talk to one of our sales
representative about the full report by providing your details in the link
below:
https://www.industryarc.com/support.php?id=15739
Related Reports:
A. Cancer
Hormone Therapy Market
https://www.industryarc.com/Report/15740/cancer-hormone-therapy-market.html
B. Cancer
Testing/Screening Market
https://www.industryarc.com/Report/15062/cancer-testing-screening-market.html
What can you expect from
the report?
The cancer
diagnostics market report is prepared with the main agenda to cover the
following 20 points:
1. Market Size by
Product Categories & Application
11. Demand Analysis (Revenue
&
Volume)
2. Market trends &
Relevant Market
Data
12. Country level
Analysis
3. Manufacturer
Landscape
13. Competitor
Analysis
4. Distributor Landscape
14. Market
Shares Analysis
5. Pricing Analysis
15. Value
Chain Analysis
6. Top 10 End user
Analysis
16. Supply
Chain Analysis
7. Product Benchmarking
17. Strategic
Analysis
8. Product Developments
18. Current
& Future Market Landscape
Analysis
9. Mergers &
Acquisition Analysis
19.
Opportunity Analysis
10. Patent Analysis
20.
Revenue and Volume Analysis
Frequently Asked
Questions:
Q. Does IndustryARC
provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting
data from our database of reports and annual subscription databases. We can
provide the following free customization:
1. Increase the level of
data in application or end user industry.
2. Increase the number
of countries in geography chapter.
3. Find out market
shares for other smaller companies or companies which are of interest to you.
4. Company profiles can
be requested based on your interest.
5. Patent analysis,
pricing, product analysis, product benchmarking, value and supply chain
analysis can be requested for a country or end use segment.
Any other custom
requirements can be discussed with our team, drop an e-mail to [email protected] to discuss
more about our consulting services.
To request for a proposal, provide your details in the below link:
https://www.industryarc.com/reports/request-quote?id=15739
Media Contact:
Mr. Venkat Reddy
Sales
Manager
Email 1:
[email protected]
Or Email 2:
[email protected]
Contact Sales:
+1-614-588-8538 (Ext-101)
About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.